Page last updated: 2024-10-30

beta-lapachone and Astrocytoma, Grade IV

beta-lapachone has been researched along with Astrocytoma, Grade IV in 2 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research Excerpts

ExcerptRelevanceReference
" In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism."3.71p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. ( El-Deiry, WS; Meng, RD, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Z1
Zhang, L1
Zhou, J1
Zhou, S1
Li, L1
Guo, X1
Feng, G1
Ma, Z1
Huang, W1
Huang, F1
Meng, RD1
El-Deiry, WS1

Other Studies

2 other studies available for beta-lapachone and Astrocytoma, Grade IV

ArticleYear
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome; Brain Neoplasms;

2017
p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma.
    Experimental cell research, 2001, Jan-15, Volume: 262, Issue:2

    Topics: Antibiotics, Antineoplastic; Apoptosis; Betulinic Acid; Colonic Neoplasms; Dactinomycin; Dexamethaso

2001